TrialClinical cancer research : an official journal of the American Association for Cancer Research2022

A Randomized, Open-Label, Multicenter, Phase 3 Study of High-Dose Vitamin C Plus FOLFOX ± Bevacizumab versus FOLFOX ± Bevacizumab in Unresectable Untreated Metastatic Colorectal Cancer (VITALITY Study).

Feng Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.